The 10 rating InvestorsObserver gives to ENDRA Life Sciences Inc (NDRA) stock puts it near the bottom of the Diagnostics & Research industry. In addition to scoring higher than 6 percent of stocks in the Diagnostics & Research industry, NDRA’s 10 overall rating means the stock scores better than 10 percent of all stocks.
NDRA has an Overall Score of 10. Find out what this means to you and get the rest of the rankings on NDRA!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With ENDRA Life Sciences Inc Stock Today?
ENDRA Life Sciences Inc (NDRA) stock has fallen -4.55% while the S&P 500 is higher by 0.76% as of 9:53 AM on Wednesday, Aug 23. NDRA has fallen -$0.05 from the previous closing price of $1.10 on volume of 2,755 shares. Over the past year the S&P 500 has gained 7.07% while NDRA has fallen -79.96%. NDRA lost -$4.22 per share the over the last 12 months.
Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
